Hot Features
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company’s principal product is Vitalzul that inhibits blood vessels formation in solid tumors.... Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company’s principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 1.0E-6 | 1 | 0.0001 | 0.000101 | 0.0001 | 550 | 0.00010091 | CS |
| 12 | 0 | 0 | 0.000101 | 0.000101 | 0.0001 | 1920 | 0.00010099 | CS |
| 26 | 1.0E-6 | 1 | 0.0001 | 0.000101 | 0.0001 | 69131 | 0.00010004 | CS |
| 52 | 1.0E-6 | 1 | 0.0001 | 0.000101 | 0.0001 | 118911 | 0.00010002 | CS |
| 156 | -0.000199 | -66.3333333333 | 0.0003 | 0.001 | 1.0E-6 | 284633 | 0.00010064 | CS |
| 260 | -0.003399 | -97.1142857143 | 0.0035 | 0.0047 | 1.0E-6 | 281469 | 0.0010075 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.